William Newton

340B Report is a leading independent news service dedicated to providing comprehensive coverage and in-depth analysis of the federal 340B drug pricing program. With a focus on developments within federal agencies, Congress, courts, states, associations, the private sector, and academia, it offers a holistic view of the 340B program landscape, making it a valuable resource for stakeholders in the healthcare sector.

As a subscription-based service, 340B Report offers its subscribers full access to its wealth of content including timely articles, breaking news, investigative reports, and exclusive webinars. Subscribers are also privy to bi-weekly newsletters directly in their inbox, keeping them up-to-date with the latest articles published on their website.

The strength of 340B Report lies in its experienced editorial team, comprised of seasoned healthcare business and policy journalists. Led by Publisher and CEO Ted Slafsky, the team brings together a wealth of knowledge and expertise in healthcare policy and pharmaceutical industry coverage.

For businesses aiming to reach decision-makers in 340B hospitals, health systems, and community health centers, 340B Report offers unique sponsorship opportunities. Sponsors benefit from the company's extensive reach within the healthcare industry, affirming 340B Report's position as an influential and trusted news source in the sector.